ArticleJCO precision oncology2020

Dual Checkpoint Blockade in a Neuroendocrine Carcinoma With Dual PD-L1/PD-L2 Amplification and High Tumor Mutational Burden.

Jun Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.